933796-07-7

Upstream product

• 933796-28-2 8-[(3,3-difluoro-1-piperidinyl)methyl]-3-iodoquinoline 
• 824-80-6 sodium 4-fluorobenzenesulfinate 
• 611-32-5 8-methylquinoline 
• 7496-46-0 8-bromomethyl-quinoline 
• 933796-27-1 3-iodo-8-quinolinecarbaldehyde 
• 933796-26-0 (3-iodo-8-quinolinyl)methanol 
• 933796-25-9 (3-iodo-8-quinolinyl)methyl acetate 

Relevant academic research and scientific papers

COMBINATION OF CB2 LIGAND AND PARACETAMOL

Combination of one or more CB2 modulators and paracetamol are useful of treating conditions which are mediated by the activity of CB2 receptors such as an immune disorder, an inflammatory disorder, pain, rheumatoid arthritis, multiple sclerosis, osteoarthritis, and osteoporosis.

QUINOLINE COMPOUNDS CAPABLE OF BINDING THE CB2 AND/OR THE 5-HT6 RECEPTOR

The present invention relates to novel quinoline derivatives such as compounds of the formula (I) which possess antagonist potency for the 5-HT6 receptor and/or are capable of selectively modulating the cannabinoid 2 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of CNS disorders.